William Y. Kim

28.4k total citations · 5 hit papers
121 papers, 8.5k citations indexed

About

William Y. Kim is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, William Y. Kim has authored 121 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 48 papers in Surgery and 39 papers in Cancer Research. Recurrent topics in William Y. Kim's work include Bladder and Urothelial Cancer Treatments (47 papers), Urinary and Genital Oncology Studies (26 papers) and Cancer, Hypoxia, and Metabolism (22 papers). William Y. Kim is often cited by papers focused on Bladder and Urothelial Cancer Treatments (47 papers), Urinary and Genital Oncology Studies (26 papers) and Cancer, Hypoxia, and Metabolism (22 papers). William Y. Kim collaborates with scholars based in United States, Canada and China. William Y. Kim's co-authors include William G. Kaelin, Norman E. Sharpless, Matthew I. Milowsky, Leaf Huang, Keiichi Kondo, Mirna Lechpammer, Sara E. Wobker, Lei Miao, Jeffrey S. Damrauer and Joel S. Parker and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

William Y. Kim

112 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Regulation of INK4/ARF in Cancer and Aging

2006 772 citations William Y. Kim, Norman E. Sharpless Cell profile →
Role ofVHLGene Mutation in Human Cancer

2004 727 citations William Y. Kim, William G. Kaelin profile →
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

2014 613 citations Jeffrey S. Damrauer, Katherine A. Hoadley et al. Proceedings of the National Academy of Sciences profile →
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

2003 481 citations William Y. Kim, William G. Kaelin et al. profile →
Renal Cell Carcinoma

2024 69 citations Tracy L. Rose, William Y. Kim profile →

Peers

Countries citing papers authored by William Y. Kim

Since Specialization

Citations

This map shows the geographic impact of William Y. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Y. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Y. Kim more than expected).

Fields of papers citing papers by William Y. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Y. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Y. Kim. The network helps show where William Y. Kim may publish in the future.

Co-authorship network of co-authors of William Y. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of William Y. Kim. A scholar is included among the top collaborators of William Y. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Y. Kim. William Y. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms 2024 ·Nature Cancer ·Xin Zhou, Ying Wang, Zhangqi Dou, Gloria Delfanti, (unknown), (unknown), (unknown), (unknown), Mark G. Woodcock, Giulia Casorati, Paolo Dellabona, William Y. Kim, Linjie Guo, Barbara Savoldo, Ageliki Tsagaratou, J. Justin Milner, Leonid S. Metelitsa, Gianpietro Dotti	21
2	The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors 2024 ·UNC Libraries ·(unknown), Lu Zhang, Matthew I. Milowsky, Feifei Xu, Jay Newby, William Y. Kim, C. Michael Lin, M. Gregory Forest, Sara E. Wobker, Samuel K. Lai, Leaf Huang	0
3	Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features 2024 ·Cancer Research Communications ·N. Ari Wijetunga, (unknown), Krishna Kanchi, Jay A. Moore, (unknown), Dexter X. Jin, Garrett M. Frampton, (unknown), Michael Repka, (unknown), David L. Corcoran, Matthew D. Galsky, Matthew I. Milowsky, Sara E. Wobker, William Y. Kim, Tracy L. Rose, Jeffrey S. Damrauer	3
4	Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer 2023 ·European Urology ·(unknown), Sara E. Wobker, Jeffrey S. Damrauer, Bentley R. Midkiff, Gabriela De la Cruz, (unknown), Leah M. Flick, Mark G. Woodcock, Petros Grivas, Marc A. Bjurlin, Michael R. Harrison, Benjamin G. Vincent, Tracy L. Rose, Shilpa Gupta, William Y. Kim, Matthew I. Milowsky	11
5	Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report 2023 ·Urology ·(unknown), (unknown), (unknown), William Y. Kim, Tracy L. Rose, Marc A. Bjurlin, (unknown)	0
6	Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer 2022 ·Nature Communications ·Jeffrey S. Damrauer, (unknown), Jeffrey A. Klomp, Mi Zhou, Elizabeth R. Plimack, Matthew D. Galsky, Petros Grivas, Noah M. Hahn, Peter H. O’Donnell, Gopa Iyer, David I. Quinn, Benjamin G. Vincent, Diane Zipursky Quale, Sara E. Wobker, Katherine A. Hoadley, William Y. Kim, Matthew I. Milowsky	27
7	Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review 2022 ·Cancer Causes & Control ·(unknown), (unknown), (unknown), (unknown), Nagireddy Putluri, Zachary Klaassen, Ashish M. Kamat, Badrinath R. Konety, William Y. Kim, Lars Dyrskjøt, David J. McConkey, Stephen J. Freedland, Peter C. Black, Siamak Daneshmand, James W.F. Catto, Stephen B. Williams	8
8	Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer 2021 ·Clinical Cancer Research ·Jeffrey S. Damrauer, Kyle R. Roell, (unknown), Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley, Halei C. Benefield, Gopa Iyer, David B. Solit, Matthew I. Milowsky, William Y. Kim, Matthew E. Nielsen, Sara E. Wobker, Guido Dalbagni, Hikmat Al‐Ahmadie, Andrew F. Olshan, Bernard H. Bochner, Helena Furberg, Melissa A. Troester, Eugene J. Pietzak	33
9	Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy 2018 ·Cancer Research ·Ryoichi Saito, Christof C. Smith, Takanobu Utsumi, Lisa M. Bixby, Jordan Kardos, Sara E. Wobker, (unknown), Shengjie Chai, (unknown), Kevin M. Byrd, Jeffrey S. Damrauer, Scott Williams, Benjamin G. Vincent, William Y. Kim	68
10	Consequences of VHL Loss on Global DNA Methylome 2018 ·Scientific Reports ·Claire M. Robinson, François Lefebvre, Betty Poon, Aurélie Bousard, Xiaojun Fan, Mark Lathrop, Jörg Tost, William Y. Kim, Yasser Riazalhosseini, Michael Ohh	12
11	Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors 2016 ·Cancer Research ·Lei Miao, Qi Liu, C. Michael Lin, Cong Luo, Yuhua Wang, Lina Liu, Weiyan Yin, (unknown), William Y. Kim, Leaf Huang	189
12	Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin 2015 ·Journal of Controlled Release ·Lei Miao, Yuhua Wang, C. Michael Lin, Yang Xiong, Naihan Chen, Lu Zhang, William Y. Kim, Leaf Huang	109
13	mTOR Inhibition Induces Compensatory, Therapeutically Targetable MEK Activation in Renal Cell Carcinoma 2014 ·PLoS ONE ·Sean T. Bailey, Bing Zhou, Jeffrey S. Damrauer, Bhavani Krishnan, (unknown), (unknown), Ming‐Qing Li, Jen Jen Yeh, William Y. Kim	18
14	Drug Efficacy Testing in Mice 2010 ·Current topics in microbiology and immunology ·William Y. Kim, Norman E. Sharpless	18
15	HIF2α cooperates with RAS to promote lung tumorigenesis in mice 2009 ·Journal of Clinical Investigation ·William Y. Kim, Samanthi A. Perera, Bing Zhou, Julián Carretero, Jen Jen Yeh, Samuel A. Heathcote, Autumn L. Jackson, Petros Nikolinakos, Beatriz Ospina, George N. Naumov, K. Brandstetter, Victor Weigman, Sara Zaghlul, D. Neil Hayes, Robert F. Padera, John V. Heymach, Andrew L. Kung, Norman E. Sharpless, William G. Kaelin, Kwok‐Kin Wong	120
16	Dominant-Negative HIF-3α4 Suppresses VHL-Null Renal Cell Carcinoma Progression 2007 ·Cell Cycle ·Mindy A. Maynard, Andrew J. Evans, Wei Shi, William Y. Kim, Fei‐Fei Liu, Michael Ohh	71
17	pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2 2007 ·Molecular Cell ·Haifeng Yang, Yoji Andrew Minamishima, Qin Yan, Susanne Schlisio, Benjamin L. Ebert, Xiaoping Zhang, Liang Zhang, William Y. Kim, Aria F. Olumi, William G. Kaelin	144
18	Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo 2006 ·The EMBO Journal ·William Y. Kim, Michal Safran, (unknown), Benjamin L. Ebert, Jonathan N. Glickman, Marcus Bosenberg, Meredith M. Regan, William G. Kaelin	193
19	The Regulation of INK4/ARF in Cancer and Aging breakdown → 2006 ·Cell ·William Y. Kim, Norman E. Sharpless	772
20	Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production 2005 ·Proceedings of the National Academy of Sciences ·Michal Safran, William Y. Kim, Fionnuala O’Connell, Lee A. Flippin, Volkmar Günzler, James W. Horner, Ronald A. DePinho, William G. Kaelin	238

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact